These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8357281)

  • 21. In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
    Tay ST; Tanty Haryanty T; Ng KP; Rohani MY; Hamimah H
    Mycoses; 2006 Jul; 49(4):324-30. PubMed ID: 16784448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytochrome P450 3A4 in vivo ketoconazole competitive inhibition: determination of Ki and dangers associated with high clearance drugs in general.
    Boxenbaum H
    J Pharm Pharm Sci; 1999; 2(2):47-52. PubMed ID: 10952769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics.
    Grimm SW; Richtand NM; Winter HR; Stams KR; Reele SB
    Br J Clin Pharmacol; 2006 Jan; 61(1):58-69. PubMed ID: 16390352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative prediction of the extent of drug-drug interaction using a physiologically based pharmacokinetic model that includes inhibition of drug metabolism determined in cryopreserved hepatocytes.
    Iwasaki S; Hirabayashi H; Amano N
    Xenobiotica; 2018 Aug; 48(8):770-780. PubMed ID: 28851254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Warfarin-fluconazole. I. Inhibition of the human cytochrome P450-dependent metabolism of warfarin by fluconazole: in vitro studies.
    Kunze KL; Wienkers LC; Thummel KE; Trager WF
    Drug Metab Dispos; 1996 Apr; 24(4):414-21. PubMed ID: 8801056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination therapy of once-weekly fluconazole (100, 150, or 300 mg) with topical application of ketoconazole cream in the treatment of onychomycosis.
    Chen X; Hiruma M; Shiraki Y; Ogawa H
    Jpn J Infect Dis; 2004 Dec; 57(6):260-3. PubMed ID: 15623951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between fluconazole and ketoconazole effectivity in the treatment of pityriasis versicolor.
    Yazdanpanah MJ; Azizi H; Suizi B
    Mycoses; 2007 Jul; 50(4):311-3. PubMed ID: 17576325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel model for the prediction of drug-drug interactions in humans based on in vitro cytochrome p450 phenotypic data.
    Lu C; Miwa GT; Prakash SR; Gan LS; Balani SK
    Drug Metab Dispos; 2007 Jan; 35(1):79-85. PubMed ID: 17020957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12.
    Cao B; Tsang PW; Tsang DN; Samaranayake LP; Wang J
    Microbios; 1996; 87(352):161-7. PubMed ID: 9050253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Q-DIPS: current approach to prediction of drug interactions].
    Leemann T; Dayer P
    Schweiz Med Wochenschr; 1992 Dec; 122(50):1930-2. PubMed ID: 1465597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of terfenadine metabolism. Pharmacokinetic and pharmacodynamic consequences.
    Kivistö KT; Neuvonen PJ; Klotz U
    Clin Pharmacokinet; 1994 Jul; 27(1):1-5. PubMed ID: 7955768
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug interactions: Part I.
    Gibaldi M
    Ann Pharmacother; 1992 May; 26(5):709-13. PubMed ID: 1591436
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole.
    Gill HJ; Maggs JL; Madden S; Pirmohamed M; Park BK
    Br J Clin Pharmacol; 1996 Sep; 42(3):347-53. PubMed ID: 8877026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of chronically administered ketoconazole on the elimination of theophylline in man.
    Heusner JJ; Dukes GE; Rollins DE; Tolman KG; Galinsky RE
    Drug Intell Clin Pharm; 1987 Jun; 21(6):514-7. PubMed ID: 3608798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluconazole: a potent inhibitor of cytochrome P-450-dependent drug-metabolism in mice and humans in vivo. Comparative study with ketoconazole.
    Morita K; Konishi H; Shimakawa H
    Chem Pharm Bull (Tokyo); 1992 May; 40(5):1247-51. PubMed ID: 1394641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion.
    Glynn AM; Slaughter RL; Brass C; D'Ambrosio R; Jusko WJ
    Clin Pharmacol Ther; 1986 Jun; 39(6):654-9. PubMed ID: 3709030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics/pharmacodynamics of ketoconazole-prednisolone interaction.
    Ulrich B; Frey FJ; Speck RF; Frey BM
    J Pharmacol Exp Ther; 1992 Feb; 260(2):487-90. PubMed ID: 1738098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ketoconazole on hepatic oxidative drug metabolism.
    Brown MW; Maldonado AL; Meredith CG; Speeg KV
    Clin Pharmacol Ther; 1985 Mar; 37(3):290-7. PubMed ID: 3971653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The possible relationship between hepatic drug metabolism and ketoconazole enhancement of cyclosporine nephrotoxicity.
    Gumbleton M; Brown JE; Hawksworth G; Whiting PH
    Transplantation; 1985 Oct; 40(4):454-5. PubMed ID: 4049500
    [No Abstract]   [Full Text] [Related]  

  • 40. The clinical pharmacology of fluconazole.
    Lazar JD; Hilligoss DM
    Semin Oncol; 1990 Jun; 17(3 Suppl 6):14-8. PubMed ID: 2191442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.